Literature DB >> 23348881

Shorter delivered dialysis times associate with a higher and more difficult to treat blood pressure.

Teena Tandon1, Arjun D Sinha, Rajiv Agarwal.   

Abstract

BACKGROUND: Shorter delivered dialysis times are associated with increased all-cause mortality. Whether shorter delivered dialysis times also associate with an increase in blood pressure (BP) and reduce the ability of probing dry weight to lower BP is unclear.
METHODS: Among patients participating in the Dry-Weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial, interdialytic ambulatory BP was recorded at baseline, 4 weeks and 8 weeks. Median intradialytic BP was also calculated at each dialysis treatment and associated with the delivered daily dialysis time.
RESULTS: The median time on dialysis at baseline was 3.6 h per treatment (range 2.5-4.5 h). At baseline, modeled median intradialytic systolic BPs were higher among those who received fewer hours of dialysis. Among subjects who did not have their dry weight probed (control group), the median intradialytic systolic BP continued to be elevated. Probing dry weight (ultrafiltration group) provoked a drop in median intradialytic systolic BP regardless of the delivered dialysis time. However, the reduction in BP was achieved after fewer sessions of dialysis when delivered dialysis was longer in duration. The pattern of change was confirmed using interdialytic ambulatory BP monitoring.
CONCLUSIONS: Fewer hours of delivered dialysis are associated with a higher systolic BP. Upon probing dry weight, compared with shorter dialysis treatment times, 4 h of delivered dialysis per session provokes reductions in systolic BP over fewer dialysis treatment sessions. Reduction of BP may lag dry-weight reduction when shorter dialysis is delivered.

Entities:  

Keywords:  hemodialysis; hypertension

Mesh:

Year:  2013        PMID: 23348881      PMCID: PMC3685306          DOI: 10.1093/ndt/gfs597

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  26 in total

Review 1.  Assessment of dry weight in hemodialysis: an overview.

Authors:  J Q Jaeger; R L Mehta
Journal:  J Am Soc Nephrol       Date:  1999-02       Impact factor: 10.121

2.  EBPG guideline on dialysis strategies.

Authors:  James Tattersall; Alejandro Martin-Malo; Luciano Pedrini; Ali Basci; Bernard Canaud; Denis Fouque; Patrick Haage; Klaus Konner; Jeroen Kooman; Francesco Pizzarelli; Jan Tordoir; Marianne Vennegoor; Christoph Wanner; Piet ter Wee; Raymond Vanholder
Journal:  Nephrol Dial Transplant       Date:  2007-05       Impact factor: 5.992

Review 3.  Analyzing change: a primer on multilevel models with applications to nephrology.

Authors:  Jocelyn E Holden; Ken Kelley; Rajiv Agarwal
Journal:  Am J Nephrol       Date:  2008-05-10       Impact factor: 3.754

4.  Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS.

Authors:  R Saran; J L Bragg-Gresham; N W Levin; Z J Twardowski; V Wizemann; A Saito; N Kimata; B W Gillespie; C Combe; J Bommer; T Akiba; D L Mapes; E W Young; F K Port
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

5.  Median intradialytic blood pressure can track changes evoked by probing dry-weight.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-18       Impact factor: 8.237

6.  Diagnosing hypertension by intradialytic blood pressure recordings.

Authors:  Rajiv Agarwal; Tesfamariam Metiku; Getachew G Tegegne; Robert P Light; Zerihun Bunaye; Dagim M Bekele; Ken Kelley
Journal:  Clin J Am Soc Nephrol       Date:  2008-05-21       Impact factor: 8.237

7.  Home blood pressures are of greater prognostic value than hemodialysis unit recordings.

Authors:  Pooneh Alborzi; Nina Patel; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2007-10-17       Impact factor: 8.237

8.  Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.

Authors:  Rajiv Agarwal; Pooneh Alborzi; Sangeetha Satyan; Robert P Light
Journal:  Hypertension       Date:  2009-01-19       Impact factor: 10.190

9.  Home blood pressure measurements for managing hypertension in hemodialysis patients.

Authors:  Rajiv Agarwal; Sangeetha Satyan; Pooneh Alborzi; Robert P Light; Getachew G Tegegne; Helmneh S Mazengia; Paulos M Yigazu
Journal:  Am J Nephrol       Date:  2009-02-27       Impact factor: 3.754

10.  Noncompliance in hemodialysis: predictors and survival analysis.

Authors:  J E Leggat; S M Orzol; T E Hulbert-Shearon; T A Golper; C A Jones; P J Held; F K Port
Journal:  Am J Kidney Dis       Date:  1998-07       Impact factor: 8.860

View more
  7 in total

Review 1.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

Review 2.  Setting the dry weight and its cardiovascular implications.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

Review 3.  Pharmacotherapy of Hypertension in Chronic Dialysis Patients.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2016-10-24       Impact factor: 8.237

4.  Hypertension Treatment for Patients with Advanced Chronic Kidney Disease.

Authors:  Arjun D Sinha; Rajiv Agarwal
Journal:  Curr Cardiovasc Risk Rep       Date:  2014-10

Review 5.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

Review 6.  Blood pressure control in conventional hemodialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Semin Dial       Date:  2018-08-06       Impact factor: 3.455

7.  Prognostic value and link to atrial fibrillation of soluble Klotho and FGF23 in hemodialysis patients.

Authors:  Albina Nowak; Björn Friedrich; Ferruh Artunc; Andreas L Serra; Tobias Breidthardt; Raphael Twerenbold; Myriam Peter; Christian Mueller
Journal:  PLoS One       Date:  2014-07-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.